Pioglitazone in Impaired Glucose Tolerance

Status Withdrawn

Clinical Trial Summary

In patients with impaired glucose tolerance (IGT), the researchers want to study the relative effects of pioglitazone, simvastatin, or the combination of both on:

- intima media thickness (IMT) as an easily assessed marker of atherosclerosis

- heart rate variability (HRV) as a marker of autonomic neuropathy

- flow-mediated vasodilatation (FMD) of the brachial artery as a marker of endothelial function

- vascular and metabolic lab parameters

Clinical Trial Description

We want to study the relative effects of pioglitazone, simvastatin or the combination of both on intima media thickness (IMT), heart rate variability (HRV), flow-mediated vasodilatation (FMD) of the brachial artery and vascular/metabolic lab parameters in patients with impaired glucose tolerance (IGT). Previous studies have shown a reduction in IMT for both pioglitazone and simvastatin in type 2 diabetics. Many patients with diabetes mellitus develop diabetic polyneuropathy which can be assessed by measuring HRV. It has been shown that pioglitazone has a positive effect on HRV in type 2 diabetics. Questions remain on the relative efficacy of pioglitazone and simvastatin on the parameters mentioned above. Also, there is only scarce data in patients with IGT (as opposed to overt diabetes mellitus). There are no data on the relative effects of pioglitazone and simvastatin on flow-mediated vasodilatation (FMD) of the brachial artery as a surrogate marker for endothelial function. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00306826
Study type	Interventional
Source	University of Leipzig
Contact
Status	Withdrawn
Phase	Phase 4
Completion date	May 2009

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05081037` - Integrated Hyperglycaemia Incentivised Postnatal Surveillance Study (I-HIPS)	N/A
Recruiting	`NCT05544266` - Rare and Atypical Diabetes Network
Recruiting	`NCT04039763` - RT-CGM in Young Adults at Risk of DKA	N/A
Active, not recruiting	`NCT05505994` - The Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on Metformin	Phase 3
Completed	`NCT03623113` - The Dietary Education Trial in Carbohydrate Counting (DIET-CARB Study in Type 1 Diabetes	N/A
Completed	`NCT03623139` - Effects of Basic Carbohydrate Counting Versus Standard Outpatient Nutritional Education in Type 2 Diabetes	N/A
Completed	`NCT03359629` - Spectrophon LTD Glucometry Monitor Accuracy
Recruiting	`NCT03682640` - Azithromycin Insulin Diet Intervention Trial in Type 1 Diabetes	Phase 2
Completed	`NCT02697305` - Incretin Effects of Branched Chain Amino Acids	N/A
Completed	`NCT01737164` - Effect of Age on Glucose and Lipid Metabolism	N/A
Terminated	`NCT00935766` - Effect of Fish Oil (Omega-3 Fatty Acids) on Arteries	Phase 3
Recruiting	`NCT03613688` - Effects of Deepure(Pu-erh Tea Extract) on Glycemic Control	N/A
Completed	`NCT04098549` - The Effect of Rapid and Slow Glucose Fall on the Subsequent Glucose Production in People With Type 1 Diabetes	N/A
Terminated	`NCT04031404` - Glucose and Non-Invasive Brain Stimulation	N/A
Active, not recruiting	`NCT03577964` - Development of Pneumonia Due to Alveolar Glucose Levels in Systemic Hyperglycemia
Active, not recruiting	`NCT03232008` - Canderel:Effects on Blood Glucose Concentration and Appetite Scores	N/A
Completed	`NCT04042142` - Glucagon Resistance in Patients With NAFLD	N/A
Active, not recruiting	`NCT05607745` - Dietary Counseling Coupled With FMT in the Treatment of Obesity and NAFLD - the DIFTOB Study	N/A
Completed	`NCT04004273` - Diabetes, Exercise and Liver Fat (DELIVER)	N/A
Completed	`NCT04082923` - Effect of Meal Texture on Glucose-metabolism and Gut Hormone Response After Bariatric Surgery	N/A